therapeutic combination comprising a aurora kinase inhibitor and antiproliferative agents

摘要

A therapeutic combination comprising (a) compound 1 of formula (A): and (b) bortezomib, in which the active ingredients of the combination are present in each case in free form or in form of a pharmaceutically acceptable salt or any hydrate.